# Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)

> **NCT04531813** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 32 (actual)

## Conditions studied

- Hypersensitivity

## Interventions

- **DRUG:** Butenafine HCl 1% (BAY1896425)
- **DRUG:** Positive Control-Sodium lauryl sulfate (SLS)
- **OTHER:** Negative Control

## Key facts

- **NCT ID:** NCT04531813
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-10
- **Primary completion:** 2013-07-01
- **Final completion:** 2013-07-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531813, "Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04531813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*